Breast Cancer Clinical Trials in Los Angeles

Showing 421-440 of 575 trials

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

NCT02946619

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Breast CancerBreast Neoplasms

University of Houston136 participantsStarted Jun 2012

Los Angeles, California, United States • Houston, Texas, United States

COMPLETEDNA< 1 mile

Health Benefits of Expressive Writing: Study One

NCT03546673

Breast CancerBreast Neoplasm

University of Houston96 participantsStarted Jul 2009

Los Angeles, California, United States • Houston, Texas, United States

COMPLETEDNA< 1 mile

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

NCT00058058

RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast of women recently diagnosed with unilateral breast cancer.

Breast CancerContralateral Breast Cancer

American College of Radiology Imaging Network1,007 participantsStarted Feb 2003

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +18 more locations

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Health Benefits of Expressive Writing: Study One

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Breast Cancer Trials in Other Cities

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

STOP Heart Disease in Breast Cancer Survivors Trial

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Other Conditions in Los Angeles